SCHEMBL27548636

SCHEMBL27548636

Nc1cccc(C(=O)Nc2cccc(OC(F)(F)F)c2)c1Cc1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.56
▸ KDR P35968 8/20 0.55
▸ FLT1 P17948 7/20 0.55
▸ P2RX1 P51575 1/20 0.50
▸ GAA P10253 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ABL1 P00519 1/20 0.46
▸ EGFR P00533 1/20 0.46
▸ CSF1R P07333 1/20 0.46
▸ PDGFRB P09619 1/20 0.46
▸ KIT P10721 1/20 0.46
▸ FLT4 P35916 1/20 0.46
▸ LMNA P02545 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27485595 0.90 KDR (0.60) NAMPTKDRFLT1MAPTABL1
SCHEMBL27466657 0.85 PTGS1 (0.64) KDRFLT1P2RX1GAATSHR
SCHEMBL27468045 0.82 KDR (0.44) KDRFLT1GAAMAPTHTT
SCHEMBL27486254 0.81 SMN1; SMN2 (0.53) NAMPTKDRMAPTHTTALDH1A1
SCHEMBL27485938 0.81 PRKCI (0.53) KDRFLT1MAPTABL1EGFR
SCHEMBL27465575 0.81 P2RX1 (0.50) KDRFLT1P2RX1MAPTHTT
SCHEMBL27484538 0.81 CYP17A1 (0.56) KDRFLT1MAPTHTTALDH1A1
SCHEMBL27548625 0.81 KDR (0.59) NAMPTKDRFLT1P2RX1MAPT
SCHEMBL27508410 0.80 KCNK3 (0.45) KDRFLT1MAPTALDH1A1HPGD
SCHEMBL27485244 0.80 ALDH1A1 (0.52) KDRGAAMAPTHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback